Abstract
1. Introduction parasite intracellular cycle [23] . Experimental evidence also shows that the 130 parasite induces the synthesis of TGF-β in cardiomyocytes and cardiac fibroblasts 131 [24], which may influence the survival of the parasite. Trypomastigote and 132 amastigote forms are able to directly activate latent TGF-β through its main 133 cysteine peptidase (CP), cruzipain, [25, 26] , which may contribute to the invasion 134 process and the genesis of Chagas disease.
135
In addition, the host immune response is controlled by TGF-β during T. cardiomyocytes, the effect is dose dependent, being observed only after the 151 treatment with high concentrations of TGF-β (> 10 ng/ml ) [34] .
152
Given that cardiac fibroblasts, the main cell type responsible for ECM 
Results

163
Modulation of fibronectin spatial distribution in different cell types after TGF-β 164
stimulation. 165 In an attempt to understand the mechanisms underlying cardiac fibrosis (Fig. 1A ) even after stimulation with TGF-β at 1 ng/ml (Fig. 1B) . However,
179
CMs stimulated with 10 ng/ml of TGF-β (Fig. 1C) The FN increase is still detected in these two cell types with addition of 10 ng/ml 
Signaling pathways triggered by TGF-β stimulation.
205
The discrepancy in response to TGF-β stimulation led us to investigate 
211
L6E9 SMAD2 phosphorylation (PS2) was 5-fold higher than CM, while CF 212 displayed 1.8-fold the PS2 levels of CM ( Fig. 2A) . Analysis of SMAD pathway 213 revealed that following stimulation of skeletal myoblasts with 1 and 10 ng/ml of 214 TGF-β, respectively, 2.1-and 2.9-fold increases in levels of PS2 in L6E9 skeletal 215 myoblasts were observed, compared to untreated L6E9 cultures ( Fig. 2A) . The 216 kinetics of TGF-β treatment of CFs revealed a 40% increase in PS2 levels after 217 stimulation with 1ng/ml TGF-β, while with 10 ng/ml stimulation a maximum 218 level of 69% increase was attained ( Fig. 2A) . Interestingly, L6E9 skeletal 219 myoblasts were more susceptible to cytokine stimulation, presenting levels of 220 PS2 10 to 13-fold higher than CM and 4-fold higher than CFs at the TGF-β 221 concentrations analyzed. CF also presented more PS2 activation than CM, 222 achieving increases of 2.5 and 2.7-fold above CM cultures when stimulated with 223 1 ng/ml and 10 ng/ml of TGF-β, respectively ( Fig. 2A) . CMs exhibit increase in 224 PS2 level only after high doses of TGF-β (10 ng/ml) ( Fig. 2A) .
225
In parallel, we also evaluated the non-canonical p38 MAPK 226 phosphorylation (phospho-p38MAPK, P-p38) pathway in CFs, CMs and L6E9 227 skeletal myoblasts after 1 h treatment with TGF-β (1-10 ng/ml). L6E9 skeletal 228 myoblasts also showed P-p38 levels 80% higher than CM and 3.7-fold higher than
229
CF at the baseline. L6E9 also showed increased sensitivity to TGF-β compared to
230
CMs and CFs, reaching 2 and 4.7-fold increases in CM and CF levels, respectively, 231 after TGF-β treatment (Fig. 2B ). An increase in phospho-p38MAPK levels was 232 observed in CF cultures stimulated with TGF-β, reaching a maximum of 45% 233 increase in concentration at 10 ng/ml (Fig. 2B) . In contrast, a 37% p38MAPK 234 activation was noticed in CMs stimulated only with 10 ng/ml of TGF-β. In all 235 concentrations of TGF-β (1-10 ng/ml), the phospho-p38MAPK levels in CF were 236 significantly lower than in CMs and L6E9 (Fig. 2B ). The addition of 1 ng/ml of 237 TGF-β to L6E9 skeletal myoblasts resulted in a 1.2-fold increase of phospho-238 p38MAPK which remained constant after treatment with higher doses of TGF-β 239 (Fig. 2B) . In contrast, even though the response of L6E9 and CM to the cytokine (Fig. 3A) . The highest FN increase was observed in CFs, with a 6.9-fold increase 273 at 1 ng/ml, and 9.4-fold increase at 10 ng/ml, while L6E9 skeletal myoblasts 274 reached a maximum of 5.5-fold enhancement at 10 ng/ml (Fig. 3) . 
Regulation of fibronectin fibrillar network assembly by T. cruzi infection 312
The FN distribution in the extracellular matrix of L6E9 skeletal myoblasts (ALK5 signaling inhibitor), reaching levels similar to controls (Fig. 6A ). 
Induction of cardiac fibroblast proliferation by T. cruzi infection and TGF-β
Discussion
420
Cardiac fibrosis is a major feature of cardiomyopathy, increasing the 421 deposition and accumulation of extracellular matrix proteins in the myocardium.
422
TGF-β is a pro-fibrogenic cytokine and exerts a significant role in the heart as a cardiomyocytes.
486
Our data showed that PS2 levels were reduced in T. cruzi-infected CF
487
cultures after the addition of TGF-β (10 ng/ml) when compared to uninfected 488 controls. The presence of the intracellular parasite in CF may modulate the 489 classical signaling pathway and prevent the signal transduction to the nucleus.
490
Studies in cardiomyocyte cultures showed that T. cruzi uptakes TGF-β for 491 multiplication and development in the host cell, using it for its own cycle [25] .
492
Also, the secreted factor from T. cruzi that inhibits TGF-β response in dermal 493 fibroblasts [44] might also be disrupting SMAD signaling in CF.
494
We demonstrated an increase of p38MAPK phosphorylation in CF after T. were washed (3 X 20 min) with PBS containing 4 % bovine serum albumin (BSA).
600
The cells were, then, incubated for 18 h at 4 °C with anti-fibronectin antibody
601
(1:400; Sigma Chemical Co. 1mg/ml pepstatin, 100 mg/ml PMSF, 1 μg/ml aprotinin and 2 mg/ml leupeptin).
615
After the lysis, electrophoresis sample buffer 5X was added (0.3 M Tris, 10% SDS, 616 0.125% Bromophenol Blue, 25% β-mercaptoethanol and 50% glycerol) and the 617 samples were heated to 100 °C for 5 min in a dry bath. After the samples cool 618 down to room temperature, the samples were stored at -20 °C. Before adding the 619 sample buffer, an aliquot of each sample was separated to quantify the total 620 protein amount using the Folin-Lowry method. 658  659  660  661  662  663  664  665  666  667  668  669  670  671  672  673  674  675  676 
